SCHEMBL23488306

SCHEMBL23488306

COc1cc(OCc2ccccc2)c(Cl)c(C)c1C(=O)OC[C@H]1O[C@@H](OC)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
TYMP P19971 1/20 0.40
XDH P47989 2/20 0.40
SLC5A1 P13866 3/20 0.39
SLC5A2 P31639 3/20 0.39
LGALS8 O00214 1/20 0.39
ERBB2 P04626 1/20 0.39
EPHA2 P29317 1/20 0.39
KDR P35968 1/20 0.39
APP P05067 2/20 0.38
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC6A2 P23975 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488516 0.85 LGALS8 (0.40) TDP1TYMPXDHSLC5A1SLC5A2
SCHEMBL23488282 0.85 LGALS8 (0.40) TDP1TYMPXDHSLC5A1SLC5A2
SCHEMBL23488579 0.85 LGALS8 (0.40) TDP1TYMPXDHSLC5A1SLC5A2
SCHEMBL23488302 0.84 TDP1 (0.46) TDP1TYMPXDHSLC5A1SLC5A2
SCHEMBL23488644 0.83 LGALS8 (0.54) SLC5A1SLC5A2LGALS8SLC6A2
SCHEMBL23488527 0.83 LGALS8 (0.46) SLC5A1SLC5A2LGALS8APPSLC6A2
SCHEMBL23488164 0.81 TDP1 (0.52) TDP1TYMPXDHLGALS8NPC1
SCHEMBL23488114 0.81 NPC1 (0.54) TDP1TYMPXDHNPC1HPGD
SCHEMBL23488711 0.80 TDP1 (0.49) TDP1TYMPXDHNPC1HPGD
SCHEMBL23488442 0.80 TYMP (0.49) TDP1TYMPSLC5A1SLC5A2LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TDP1 4093/4885TYMP 2235/4885XDH 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.